Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

11.59
Delayed Data
As of Feb 22
 +0.13 / +1.13%
Today’s Change
7.20
Today|||52-Week Range
16.80
+16.83%
Year-to-Date
No recent news for Omeros Corp.

Today’s Trading

Previous close11.46
Today’s open11.33
Day’s range11.32 - 12.07
Volume432,156
Average volume (3 months)640,197
Market cap$491.8M
Dividend yield--
Data as of 02/22/2017

Growth & Valuation

Earnings growth (last year)+9.91%
Earnings growth (this year)+8.25%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+2,406.31%
P/E ratioNM
Price/Sales43.74
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INOInovio Pharmaceutica...-0.20-2.94%
CRHMCRH Medical Corp0.000.00%
RARXRa Pharmaceuticals I...-0.59-2.63%
SCLNSciClone Pharmaceuti...-0.10-1.01%
Data as of 4:00pm ET, 02/22/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$13.5M
Annual profit (last year)-$75.1M
Net profit margin-555.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts


Search for Jobs